Regular biography
Dr Christopher R Coxon is a Senior Lecturer in Medicinal Chemistry at the University of Edinburgh, School of Chemistry. His research focuses on medicinal chemistry, peptide synthesis, fluorine chemistry, and the development of chemical probes for disease detection and treatment. Dr Coxon's work includes the design of peptides to modulate GPCRs involved in neurological and neurodegenerative diseases, such as migraine and Parkinson’s disease, as well as the development of fluorinated tools for chemical biology and biomarker detection using 19F NMR. He is also the Co-founder and Director of Pepmotec Ltd, a peptide synthesis spin-out company. Dr Coxon has held academic positions at Durham University and Liverpool John Moores University, and he is Programme Director of the MSc in Medicinal and Biological Chemistry at the University of Edinburgh.
Scholar-generated biography
Christopher R Coxon is a researcher in medicinal chemistry with a focus on peptides and fluorine chemistry. His work explores the role of fluorine in peptide and protein chemistry, including the development of fluorinated prolines as conformational tools and the use of perfluoroaryl reagents in modified peptide systems. Coxon has also contributed to the study of peptide-based drug delivery systems, particularly for targeting the brain, and has investigated the structural composition of approved peptide therapeutics. His research includes the synthesis of novel amino acids and tripeptides, as well as the development of tools for automated flow synthesis. His work emphasizes the application of fluorine chemistry in drug design and delivery.